Geoffrey S Dow insider trades: 60 Degrees Pharmaceuticals (SXTP) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Geoffrey reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | SXTP | ↑ Buy | 7,350 | $1.38 | $10K | Direct | Jun 15, 2026 (3d) |
| Dec 15, 2025 | SXTP | ↑ Buy | 9,670 | $0.80 | $8K | Direct | Dec 16, 2025 (1d) |
| Dec 11, 2025 | SXTP | ↑ Buy | 12,963 | $0.94 | $12K | Direct | Dec 12, 2025 (1d) |
| Dec 9, 2024 | SXTP | ↑ Buy | 73,951 | $1.21 | $90K | Direct | Dec 9, 2024 (0d) |
| Nov 21, 2024 | SXTP | ↑ Buy | 7,000 | $0.91 | $6K | Direct | Nov 21, 2024 (0d) |
| Jan 31, 2024 | SXTP | ↑ Buy | 25,974 | $0.38 | $10K | Direct | Feb 2, 2024 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Geoffrey S Dow's insider trades
Geoffrey S Dow is President and CEO at 60 Degrees Pharmaceuticals (SXTP). Since Jan 31, 2024, Geoffrey has reported 6 open-market purchases worth $136K and no sales on SEC Form 4. In the last 12 months: 3 buys ($30K).
Their filings also include grants and awards (6 filings), option exercises (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SXTP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.